• Chest · Mar 2014

    The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among egyptians.

    • Emad Ibrahim, Abeer Kassem, and Nermin Zakaria.
    • Chest. 2014 Mar 1;145(3 Suppl):515A.

    Session TitlePulmonary Hypertension Posters IISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: This study analyses for the endothelin-1 (ET-1) level, and gene polymorphisms for endothelin-1 (EDN1 gene) in patients with pulmonary arterial hypertension (PAH) in Egypt.MethodsCross-sectional study. Alexandria university teaching hospital. Subjects were divided into two groups of matched age and sex were allocated. The first group consisted of thirty subjects, ≥ 18 years one group with no apparent evidence of disease free from pulmonary hypertension after full medical history, examination, and selected investigations (control group). The second group consisted of thirty subjects, ≥ 18 years, suffering from pulmonary hypertension. All subjects were screened for Endothelin-1(ET-1) and Gene polymorphism.ResultsThis study analysed the frequency and the potential role of endothelin -1 and gene polymorphisms, the +134del/insA, located in the gene encoding for Endothelin-1 (EDN1) in PAH. Thirty patients with pulmonary hypertension (12 [40%] men) were included in the study (Table 1). The mean age of the patients was 53.5±12.8 years range from 34 to 72 years. The two groups of patients and control subjects were matched as regard the age and gender. The endothelin-1 mean was 1.8±1.3 fmol/ ml with range from 0.3 to 3.8 fmol/ ml in the patients group. The endothelin-1 mean was 0.7±0.05 fmol/ ml with range from 0.6 to 0.75 fmol/ ml in the patients group. There was a significantly higher level of endothelin-1 in the group of pulmonary hypertension (p<0.001). For the groups of polymorphisms studied, there was three genotypes (GT, TT, and GG), no substantial differences in genotype and allele distributions for +134 del/insA located in EDN1 gene, between PAH patients and control population, were observed (DF = 1; C.I.= 95.0; and p = 0.226). The genotype GG show the highest level of endothelin while the TT type show the lowest value of endothelin-1. Also, we found a significant relation between the higher endothelin-1 level and the lower oxygen saturation (p= 0.049), and the higher meanPAP (p= 0.004).ConclusionsIn conclusion, our findings suggest a potential link between endothelin-1 level and specific genotypes in the EDN1 gene and susceptibility for PAH with a worse haemodynamic profile. Further investigations are warranted to understand the molecular basis and to confirm the potential clinical importance of these findings on larger cohorts of patients with PAH.Clinical ImplicationsThis mayl impact on the management of PAH of Egyptian patients in the future.DisclosureThe following authors have nothing to disclose: Emad Ibrahim, Abeer Kassem, Nermin ZakariaNo Product/Research Disclosure Information.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.